Production (Stage)
SBC Medical Group Holdings Incorporated
SBC
$4.55
$0.7118.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.31% | 18.40% | -- | -- | -- |
| Total Depreciation and Amortization | -67.43% | -68.98% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 159.96% | 154.39% | -- | -- | -- |
| Change in Net Operating Assets | -181.45% | -512.83% | -- | -- | -- |
| Cash from Operations | -63.14% | -59.38% | -- | -- | -- |
| Capital Expenditure | 65.01% | 64.21% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -95.97% | -100.00% | -- | -- | -- |
| Cash Acquisitions | -686.22% | -686.22% | -- | -- | -- |
| Divestitures | 97.97% | -- | -- | -- | -- |
| Other Investing Activities | -110.44% | -163.75% | -- | -- | -- |
| Cash from Investing | -971.06% | -663.25% | -- | -- | -- |
| Total Debt Issued | 93.22% | -1.83% | -- | -- | -- |
| Total Debt Repaid | 92.71% | 94.78% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.07% | 14.07% | -- | -- | -- |
| Cash from Financing | 1,725.62% | 274.31% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 155.29% | -56.20% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.64% | -57.06% | -- | -- | -- |